{"cursor":"10771","size":15,"audio":[],"currentlang":"en","article":"\n\n{{Infobox company| company_name = Actavis Inc | company_logo = |\n | type = Public traded_as = S&P 500 Component foundation = Libertyville,\n | Illinois, USA (Spring 1984) founder = Allen Chao, Ph.D. and David Hsia, Ph.D.\n | location = Parsippany, New Jersey, with international headquarters in Zug,\n | Switzerland locations = 30 manufacturing facilities, 17 global R&D centers, a\n | distribution center, and marketing/sales facilities worldwide. area_served =\n | Worldwide key_people = Paul Bisaro, President & CEO industry = Brand and\n | generic pharmaceuticals, and pharmaceutical research and development.\n | products = Brand and generic pharmaceuticals services = market cap = revenue\n | = US$ 5.9 billion(2012) operating_income = US$ 320.8 million (2012)\n | net_income = US$ 98.3 million (2012) owner = num_employees = 17,000 employees\n | worldwide (2013) homepage = http://www.actavis.com\nhttp://www.edenbiodesign.com }} ]]\n\n'Actavis' became the new name for global pharmaceutical Company 'Watson\nPharmaceuticals Inc.' on January 24, 2013. At the same time the Company began\ntrading under a new symbol â (NYSE:ACT\n[http://www.nyse.com/about/listed/lcddata.html?ticker=ACT] â on the New York\nStock Exchange.\n\nThe name change followed the Companyâs acquisition of the global Generics\nPharmaceutical Company Actavis Group in October 2012.\n\nActavis, Inc. is a global, integrated specialty pharmaceutical company focused\non developing, manufacturing, and distributing generic, brand, and biosimilar\nproducts. The Company has global and U.S. headquarters in Parsippany, New\nJersey, and international headquarters in Zug, Switzerland.\n\nActavis is the world's third-largest generics prescription drug manufacturer.\nOperating as Actavis Pharma, the Company develops, manufactures and markets\ngeneric, branded generic, legacy brands, and Over-the-Counter (OTC) products in\nmore than 60 countries. The Company is ranked in the top 3 in 12 global markets,\nthe top 5 in 16 global markets, and in the top 10 in 33 global markets. Actavis\nPharma also develops and out-licenses generic pharmaceutical products outside\nthe U.S. through its Medis third-party business, the worldâs largest generic\npharmaceutical out-licensing business. Medis has more than 300 customers\nglobally, and offers a broad portfolio of more than 200 products.\n\nActavis Specialty Brands is the Companyâs global branded specialty\npharmaceutical business, which develops and markets a portfolio of approximately\n40 products principally in the United States and Canada that are focused in the\nUrology and Women's Health therapeutic categories. Actavis Specialty Brands is\ncommitted to developing and marketing biosimilars products in Womenâs Health,\nOncology and other therapeutic categories, and currently has a portfolio of 5\nbiosimilar products in development. Actavis Global Operations has more than 30\nmanufacturing and distribution facilities around the world, with a capacity of\napproximately 40 billion units annually. Actavis Global Operations also includes\nAnda, Inc., the fourth-largest U.S. generic pharmaceutical product distributor\nin the United States.\n","linknr":262,"url":"Watson_Pharmaceuticals","recorded":1362675428,"links":43,"instances":[],"pdf":[],"categories":["Companies listed on the New York Stock Exchange","Pharmaceutical companies based in New Jersey"],"headings":["History","Company Evolution","Locations and facilities","External links"],"image":["//upload.wikimedia.org/wikipedia/en/thumb/9/99/Question_book-new.svg/50px-Question_book-new.svg.png","//upload.wikimedia.org/wikipedia/en/4/4a/Actavis-logo.png","//upload.wikimedia.org/wikipedia/commons/thumb/e/ed/Actavis.JPG/275px-Actavis.JPG","//bits.wikimedia.org/static-1.21wmf10/skins/common/images/magnify-clip.png","//upload.wikimedia.org/wikipedia/commons/thumb/d/db/California_county_map_%28Inland_Empire_highlighted%29.svg/23px-California_county_map_%28Inland_Empire_highlighted%29.svg.png","//upload.wikimedia.org/wikipedia/commons/thumb/b/b6/Factory_1b.svg/32px-Factory_1b.svg.png","//bits.wikimedia.org/static-1.21wmf10/skins/vector/images/search-ltr.png?303-4","//bits.wikimedia.org/images/wikimedia-button.png","//bits.wikimedia.org/static-1.21wmf10/skins/common/images/poweredby_mediawiki_88x31.png"],"tags":[],"members":[],"related":["S&P_500","Parsippany,_New_Jersey","New_Jersey","Zug,_Switzerland","Switzerland","United_States_dollar","United_States_dollar","United_States_dollar","NYSE","Headquarters","Parsippany,_New_Jersey","New_Jersey","Zug,_Switzerland","Switzerland","Allen_Chao,_Ph.D."]}